treatment of the ICU elderly trauma cohort. A recent retrospective analysis of data by Lee et al showed that in-hospital mortality rate of the elderly (defined as above 65 years) was twice that of younger patients; the elderly also had significantly higher rates of chest injuries that demanded a longer ICU stay 9 . A retrospective study on elderly trauma by Day et al found that age was an important factor in survival, but that survivors had good functional recovery 10 . The purpose of this study was to characterise: 1) the hospital mortality, and its determinants, of elderly trauma patients admitted to an Australian tertiary ICU and high dependency unit (HDU) and 2) the treatment cost of these patients allowing for the heterogeneous costing methodology that has been applied in intensive care setting 11, 12 .
METHoDS

Setting
This was a retrospective cohort study conducted at a major adult tertiary care trauma centre of South Australia (Royal Adelaide Hospital [RAH] ). The hospital provides services in all the major medical and surgical specialties. The ICU is a mixed 24-bed medical and surgical unit, with an additional 10 HDU beds. The study was approved by the RAH Human Research Ethics Committee.
Patients
The RAH electronic trauma registry was examined for the period of January 2000 to December 2005. Patients entered into the trauma registry fulfilled the following criteria: all patients admitted to the hospital who had sustained injury(ies) falling within the ICD9-CM code range 800.0 to 959.9 as a result of a traumatic event (ICD10-AM code range S00-T98 excluding poisoning from 1 July 2000) and died within the emergency department, or • were admitted to ICU/HDU, or • had an injury severity score (ISS) >16, or • patients to whom the trauma team was called, or • patients who were retrieved (by the RAH Medi-• flight Medical Team from South Australia and interstate). Identified trauma patients were grouped into three major age categories: aged ≥65 years admitted into ICU/HDU; aged ≥65 years admitted into general ward and aged <65 years admitted into ICU/HDU. Elderly patients were defined as age of ≥65 years 3, 9 .
Data collection
The following data were obtained for all patients: age, gender, ISS, duration of ventilation (in hours), length of ICU and hospital stay (days), the Charlson comorbidity index (CCI) and outcome at hospital discharge (dead or alive). The CCI, which measures the underlying severity of comorbid illness, scores from 1 to 6 for 19 specific medical diagnoses, representing increasing levels of illness 13 . The CCI was computed by examination of the electronic administrative data listings for the ICD-10 codes of each patient and subsequent processing by the Stata™ module "Charlson" 14, 15 . Binary (scored 0,1) categorical variables were generated to reflect patient admission on Saturday or Sunday ("weekend"), admission between 1800 and 0600 hours the following day ("after-hours") and after-hours not at the weekend ("afterhours-weekday"). Acute physiological and chronic health evaluation scores were unable to be utilised due to incomplete data collection.
Information on the cost of hospital stay (≡total costs) of the patients was gathered from the RAH Finance Department, Case Mix and Clinical Costing Unit. The sum total costs consisted of the drug, medical/surgical, prosthesis, operating theatre and recovery, allied health, pathology, imaging, ICU, medical salaries/wages, nursing salaries/wages, indirect overhead and miscellaneous costs (see Appendix 2 on the online version).
South Australian health consumer price indices (CPI) 16 and Australian versus US dollar yearly average exchange rates 
Statistical analysis
Variables were reported as mean (SD) unless otherwise indicated. Pearson's chi-squared was used for the categorical variables and analysis of variance was performed by the kruskal-Wallis non-parametric test; for summarising raw variable time-change, simple non-parametric trend tests were used. Distributions of variables of interest were visualised by trellis plots, based on a formula with the structure y~x  a×b, where y is a continuous or factor variable, x is continuous, and a and b are factors 18 . Hospital mortality was modelled using logistic regression. ISS 21 . The final model was developed on training (75% of data) and determination sets (25% of data); the random samples being stratified by calendar year. The model chi-squared was calculated for each parameter to adjudge the relative 'importance' of the parameter 22 . The total cost of care and the mean daily cost of care (over the period of stay in ICU and hospital) were calculated; this was expressed as either costs per current year or adjusted 23 by health CPI to 2005 Australian dollars, as indicated in the text. Cost predictors for total hospital costs (as A$ 2005) were determined by ordinary least squares regression analysis using log transformed costs and comparison with a raw-cost regression model was also undertaken (including the concordance of predicted and raw cost 24 ). Final R 2 , as the squared correlation of predicted versus raw costs, was reported on the back-transformed 'dollar' scale, as the expectation was that regression with log transformed dependent variable would yield a higher R 2 than using raw costs 25 . Stability of both the mortality cost model was determined by a split-sample technique (75% determination, 25% validation sub-sets); overall model parsimony was sought.
With respect to the analysis of the impact of outcome (dead or alive) on cost-of-care; mortality outcome, considered as an independent variable in a regression analysis, may have been subject to "endogenous variable bias" 26 . Hence the cost model was re-estimated using a treatment-effects model 27 , where specific allowance is made for the correlation of independent predictors and the error terms.
Further details of the statistical approaches are provided in Appendix 1 (see online version). Statistical significance was ascribed at the 0.05 level. Analyses were performed using the Stata™ statistical software (V10.1, 2008: Stata Corporation, College Station TX, USA).
RESULTS
Demographics: patient characteristics and outcomes
During the study period, January 2000 through December 2005, there were 1617 patients aged <65 years admitted into the ICU, 272 patients aged ≥65 years admitted into ICU and 610 patients aged ≥65 years admitted to the hospital wards. The ISS of patients admitted to ICU, ≥65 years and <65 years of age, was not significantly different (P=0.29); but, not surprisingly, the ISS of elderly patients admitted to the ward was significantly lower (P=0.001). Both groups admitted to ICU were ventilated in similar proportions but not for the same time period (P=0.0004). Raw hospital mortalities for the groups created by the interaction of agecategory×ventilation status were: ICU age <65 years non-ventilated, 3.1%; ICU, age <65 years ventilated, 17.8%; ICU age ≥65 years nonventilated, 11.3%; ICU age ≥65 years ventilated, 61.5%; ward: age ≥65 years non-ventilated, 4.1%. A modest decline in the overall proportion of patients aged <65 years occurred over the time of the study, but not for the proportion ventilated (non-parametric trend test; P=0.014 and P=0.25 respectively). A small decrease (1% per year) in mean ISS was also demonstrated over time (least squares regression, P=0.001). Additional patient demographics are shown in Table 1 . Table 2 . As the logistic model was primarily discriminative-explanatory in intention, the relatively poor final calibration status of the whole data-set-model was accepted 28 . Mortality oRs were increased with increases in CCI and over calendar years and decreased for all age×ventilation-status combinations compared with ventilated ICU patients, aged ≥65 years. Neither gender nor time(s) of admission demonstrated a mortality effect (P ≥0.2) and no significant interactions were demonstrated between 1) ISS Figure 2 . Ventilated elderly patients sustained increased costs compared with the non-ventilated sub-cohorts and there were variable cost increments over the time period of the study. Average daily ICU and hospital costs, 2000 to 2005, are seen in Table 3 . When adjusted for health CPI (' A$ 2005' costs), relatively modest and irregular increments occurred in both ICU and hospital costs.
Covariate cost-effects from the log-cost regression analysis are seen in Table 4 . Statistical advantage for modelling the effect of ISS by a fractional polynomial (0.5, 3; Figure 1 , right panel) was demonstrated in the determination set (R 2 =0.42) and the polynomial effect as (0.5, 3) was sustained in the validation set (R 2 =0.41); final coefficients were reported for the whole data set (R 2 =0.42; Table 5 ). A small (2.4%) yearly cost increment was evident; the year effect being modelled as a FP=fractional polynomial model (see Table 4 ). linear continuous variable, there being no evidence of non-linearity. No interaction between calendar year and categorical variables, nor between categorical variables was apparent (P ≥0.59). On the 'dollar' scale, the final R 2 of the log-cost model was 0.22. As expected, the log cost model was superior to the raw cost model in terms of residual analysis and the concordance of predicted and raw costs was superior (0.39 vs 0.32, respectively). Further details of cost model development are provided in Appendix 1, "Results, Cost model".
Mean overall difference between those alive and dying, for raw and predicted (A$ 2005) costs (fractional polynomial log-cost model), was estimated at $7688 and $9841 respectively. In the treatmenteffects model (Table 4) , modest changes occurred in the parameter estimates compared with the fractional polynomial model, with the difference in the percentage change for the outcome effect (dead vs alive) being 19.3% (-82.2% vs -62.9%, respectively). The treatment-effects model was well specified with respect to residual analysis and there was minimal evidence of heteroscedasticity (nonconstant variance; see also Appendix 1, "Results, Cost model"). Mean overall difference, alive vs dead, was $11,142 (A$ 2005).
Mean cost comparisons (alive vs died, estimated for baseline categories (Table 4) , A$ 2005), for fractional polynomial least squares regression versus treatment-selection model and referenced to raw cost, over calendar year and between age categories, are seen in Table 5 . Predicted costs for surviving patients generally exceeded cost for those dying and the differential was increased for the treatment -effects model. Cumulative differences, alive vs died, over year and age categories, were: raw costs, $213,382; fractional polynomial model, $257,620; and treatment-effects model, $291,748.
DISCUSSIoN
Mortality outcome
The adverse impact of age upon mortalityoutcome 7, 29 was confirmed in the current study of elderly patients admitted into intensive care. The observed mortality rate observed was consistent with the findings of the recent National Trauma Registry, with an estimated 30% elderly mortality at hospital discharge following a major trauma (ISS >15), and with reports published in North America and Europe. Despite higher mortality rates in the elderly compared with the younger age group, these rates were comparable with other disease outcomes such as severe sepsis 30 .
In agreement with the Major Trauma outcome Study (MToS), ISS increments were associated with increased mortality 31 , which was not a linear function of the ISS (Figure 1) , a finding similar to the modelled effect of the acute physiological and chronic health evaluation III score on mortality outcome 32 . The injury severity score has proved popular over time despite deficiencies when there is more than one injury per body system. More insightful would have been a detailed breakdown of the injury severity scores to that of individual body systems and analysis of the relationship with overall mortality. It has been shown that head injury in the elderly, compared with younger patients, is associated with decreased surgical intervention and higher mortality 33 ; similarly, rib fractures are also associated with increased risks of death 34 . Further studies are needed to look at the differential impact of specific organ injuries on the management and survival of the elderly.
The impact of CCI on prognosis in the spectrum of critically ill patients has been variable 35 . The limited range of the CCI scores observed in the current study were in general agreement with Gabbe et al 36 and may have simply represented the characteristics of the cohort of elderly patients; that is, those in better health, being of increased mobility, were more likely to suffer from trauma. of interest, 'coagulopathy', which may be important in the trauma setting, does not contribute to the CCI components 37 . The number of patients prescribed anticoagulants in Australia is increasing at a yearly rate of 9% 38 . It is possible that over the ensuing years, with the increase use of antiplatelet therapy and anticoagulants, bleeding risks in this cohort of trauma patients will increase significantly and have greater impact on outcomes.
A requirement for artificial ventilation predicted mortality (Table 2 ) and in the age category ≥65 years, the ventilation hours were also notably longer. Mechanical ventilation is known to be a predictor of mortality in various other disease states, more so in the elderly 39 . Gender, on the other hand, had no demonstrable effect on survival in our study. While experimental data seem to support the influence of gender on disease processes, with the female gender conferring benefit, clinical evidence in trauma patients has been conflicting 40 . The reasons for the modest mortality increment over time were not immediately obvious, there being no significant interaction between calendar year and the age×ventilation-status combinations (see "Results, Hospital mortality outcome: logistic regression model" above) and the ISS demonstrated a small decrease with time. The most plausible explanation would appear to be the decrease in the overall proportion of patients aged <65 years over the study period.
Costs
A 'top-down' costing of care was used as a broad assessment of resource utilisation. There were 13 identified cost-buckets that encompassed both cost not directly related to the individual patient care (but necessary for daily maintenance of services) and that which was directly related to cost incurred in care. This method, though not standardised across hospitals in Australia, has been advocated and applied in other studies as a means to uniformly define and compare ICU expenditure 12, 41 . While data on ICU trauma costing is scarce, this study has revealed some interesting comparisons. The total and average daily cost of care for patients in the ICU age categories were comparable with other Australian studies. Rechner (Table 3) , albeit the acquisition of treatment cost were calculated differently. The significant cost contributors, for example, drugs, pathology and radiology noted by Rechner et al were not included in the ICU costing (see Appendix 2 on the online version) but were instead factored into the 'total hospital bill'. Trauma patients would have incurred much higher operating theatre cost, once again captured only in the total hospital cost. In Australia, blood transfusion is funded by the Australian Red Cross, trauma patients being a major consumer, and this may have under-estimated cost when compared with other jurisdictions. Although international comparisons may reflect different treatment-cost acquisition, the above reported costs would appear to be less than the US$ (2004) daily ICU cost of $2575 (≡A$3420) reported by Milbrandt et al 23 . of interest, the latter authors reported stable ICU daily costs over the period 1994 to 2004, whereas the present study, albeit in trauma patients, found an annual increment (in A$ 2005) of 2.4%, against a background of an annual increase in ICU length of stay of 0.83%.
The factors that increased mortality were also those factors that increased the cost of care, while 'death' in itself somewhat paradoxically limited further escalation of cost, although the interaction between 'outcome' and ' Age-category' was nonsignificant (global Wald test, P=0.31). This observation differs from that found by Seguin et al, where total expenditure on non-survivors was greater 42 .
Critique of methodology
The current study derived its patient cohort and cost-structure from a single tertiary referral centre, and obviously inferences may not be relevant to other jurisdictions. Although long-term follow-up was not established, the restriction of follow-up to hospital discharge was of advantage in that a correspondence was established between variables predicting (hospital) outcome and costs. Long-term functional outcomes, increasingly recognised as meaningful outcome measures, were also not measured. Intensive care obviously serves the acute-care environment, but it is appropriate that the cost of protracted rehabilitation, any decrement in quality of life and other social-economic costs be considered in the period that follows 'successful' intensive care. Age has always been modelled in health economics as having higher impact upon future cost. This supposition has been recently reassessed with the demonstration that the time-period proximate to death is the period of substantive cost escalation (ICU care being a part thereof) 43 . The final cost model had an R 2 on the dollar scale of 0.22, which was modest, but comparable with other studies and overviews 11, 44, 45 . The mortality effect of outcome on cost in the log-cost least squares model was biased upwards (-62.9% vs -82.2%) with respect to that of the treatment-effects model, which addressed the endogeneity of 'outcome' in the least squares regression (identified by the correlation of the error terms of the separate determination of costs and outcome in the treatment-effects regression; see Appendix 1 on the online version). This approach may thus be preferred when binary endogenous 'outcome' variables are used as independent regression variables 46, 47 ; an analytic direction previously comment upon 39 . This being said, the overall predicted cost difference, alive versus dead, between the two approaches was modest (Table 5) .
CoNCLUSIoN
Those factors decreasing survival time were also associated with cost increments, although mortality per se was associated with an overall cost decrease. Costs increased minimally over the calendar year span of the study. Cost methodology must appropriately address endogenous variable bias.
